Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Dec 22, 2022 · Find out the generic and brand names of cancer drugs approved by the FDA for ovarian, fallopian tube, or primary peritoneal cancer. Also see common drug combinations and their links to NCI's Cancer Drug Information summaries.
Ovarian cancer - Diagnosis and treatment - Mayo Clinic
May 9, 2023 · Learn about the tests, procedures and stages of ovarian cancer diagnosis, and the treatment options, such as surgery, chemotherapy, targeted therapy and hormone therapy. Find out how Mayo Clinic can help you with your ovarian cancer-related health concerns.
List of 39 Ovarian Cancer Medications Compared - Drugs.com
Jun 11, 2024 · Learn about the different types of drugs used to treat ovarian cancer, such as chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Compare ratings, reviews, and side effects of 38 ovarian cancer medications.
Ovarian cancer: New treatments and research
May 1, 2024 · If you've been diagnosed with ovarian cancer, he wants you to know there is hope. Here's why: New targeted therapies are improving survival. Surgery and chemotherapy are no longer the only options for ovarian cancer treatment. Targeted therapies use drugs to target and attack cancer cells.
Ovarian Cancer Treatment | How to Treat Ovarian Cancer
Learn about the types of local and systemic treatments for ovarian cancer, such as surgery, chemotherapy, radiation, and hormone therapy. Find out how to make treatment decisions, get support, and access clinical trials and complementary methods.
Targeted Drug Therapy for Ovarian Cancer
Learn about the types and uses of targeted drugs for ovarian cancer, including PARP inhibitors that can help women with or without BRCA gene mutations. Find out how these drugs work, their side effects, and how they are given.
Antibody drug conjugates make strides in ovarian cancer with …
Feb 12, 2024 · UCLA Health enrolled the highest number of participants in the U.S. in a trial that led to FDA approval of mirvetuximab soravtansine, an antibody drug conjugate (ADC) for ovarian cancer. The ADC improved survival, tumor shrinkage and reduced side effects compared to …
Mirvetuximab Soravtansine-Gynx Approved for Ovarian Cancer
Apr 24, 2024 · Platinum-resistant ovarian cancer has proven difficult to treat, but with the Food and Drug Administration’s recent full approval of mirvetuximab soravtansine-gynx (Elahere), some people in this situation now have a new treatment option.
PARP Inhibitors as Initial Treatment for Ovarian Cancer
Oct 29, 2019 · PARP inhibitors are drugs that block the repair of broken DNA and may benefit women with advanced ovarian cancer. Learn about the latest results from three trials and the FDA approval of olaparib plus bevacizumab for women with HRD tumors.
Novel Therapeutics: Response and Resistance of Ovarian Cancer
Combination of these drugs with the proteasome inhibitor bortezomib resulted in enhanced ovarian cancer cell death (NT-111). Similarly, Dr. Yang Yang-Hartwich and colleagues explored the UPR pathway as a potential target for overcoming chemoresistance in ovarian cancer.